Argyrios N. Theofilopoulos

Argyrios N. Theofilopoulos's AcademicInfluence.com Rankings

Biology

#6306

World Rank

#8991

Historical Rank

Immunology

#320

World Rank

#333

Historical Rank

biology Degrees

Download Badge

Biology

Why Is Argyrios N. Theofilopoulos Influential?

(Suggest an Edit or Addition)

(See a Problem?)

Argyrios N. Theofilopoulos's Published Works

Number of citations in a given year to any of this author's works

Total number of citations to an author for the works they published in a given year. This highlights publication of the most important work(s) by the author

Published Works

Spontaneous murine lupus-like syndromes. Clinical and immunopathological manifestations in several strains (1978) (1588)
TYPE I INTERFERONS (/) IN IMMUNITY AND AUTOIMMUNITY (2005) (1087)
Murine models of systemic lupus erythematosus. (1985) (878)
Type I interferons (alpha/beta) in immunity and autoimmunity. (2005) (756)
The Raji cell radioimmune assay for detecting immune complexes in human sera. (1976) (677)
Type-I Interferon Receptor Deficiency Reduces Lupus-like Disease in NZB Mice (2003) (537)
TLR-dependent and TLR-independent pathways of type I interferon induction in systemic autoimmunity (2007) (492)
The biology and detection of immune complexes. (1979) (437)
Etiopathogenesis of Murine SLE 1 (1981) (422)
A regenerative approach to the treatment of multiple sclerosis (2013) (401)
Lupus susceptibility loci in New Zealand mice. (1994) (395)
T cell homeostatic proliferation elicits effective antitumor autoimmunity. (2002) (363)
Interferon-gamma is required for lupus-like disease and lymphoaccumulation in MRL-lpr mice. (1998) (347)
The multiple pathways to autoimmunity (2017) (340)
Analysis of T cell function in autoimmune murine strains. Defects in production and responsiveness to interleukin 2 (1981) (309)
A spontaneous rheumatoid arthritis-like disease in MRL/l mice (1982) (303)
The pathogenic effect of IgG4 autoantibodies in endemic pemphigus foliaceus (fogo selvagem). (1989) (266)
Loci predisposing to autoimmunity in MRL-Fas lpr and C57BL/6-Faslpr mice. (1998) (255)
Circulating immune complexes in the idiopathic interstitial pneumonias. (1978) (254)
The basis of autoimmunity: Part I. Mechanisms of aberrant self-recognition. (1995) (245)
Genesis and evolution of antichromatin autoantibodies in murine lupus implicates T-dependent immunization with self antigen. (1993) (237)
The basis of autoimmunity: Part II. Genetic predisposition. (1995) (217)
Interferons as pathogenic effectors in autoimmunity (2005) (216)
The role of IFN-gamma in systemic lupus erythematosus: a challenge to the Th1/Th2 paradigm in autoimmunity (2001) (208)
Association of circulating retroviral gp70-anti-gp70 immune complexes with murine systemic lupus erythematosus (1979) (202)
The nature of immune complexes in human cancer sera. (1977) (194)
Increased expression of the FoxP3 functional marker of regulatory T cells following B cell depletion with rituximab in patients with lupus nephritis. (2007) (192)
Isolation of human T and B lymphocytes by rosette formation with 2-aminoethylisothiquronium bromide (AET) -treated sheep red blood cells with monkey red blood cells. (1976) (172)
Etiopathogenesis of murine SLE. (1981) (170)
Induction of murine autoimmune disease by chronic polyclonal B cell activation (1983) (168)
Identification of a B cell differentiation factor(s) spontaneously produced by proliferating T cells in murine lupus strains of the lpr/lpr genotype (1983) (164)
Endosomal TLR signaling is required for anti-nucleic acid and rheumatoid factor autoantibodies in lupus (2009) (157)
BINDING OF SOLUBLE IMMUNE COMPLEXES TO HUMAN LYMPHOBLASTOID CELLS (1974) (155)
Distribution of lymphocytes identified by surface markers in murine strains with systemic lupus erythematosus-like syndromes (1979) (154)
Fas (CD95) participates in peripheral T cell deletion and associated apoptosis in vivo. (1995) (152)
Splenic immunoglobulin-secreting cells and their regulation in autoimmune mice (1980) (150)
CIRCULATING IMMUNE COMPLEXES IN MULTIPLE SCLEROSIS AND OTHER NEUROLOGICAL DISEASES (1976) (146)
Circulating immune complexes in infective endocarditis. (1976) (145)
Treatment of murine lupus with cDNA encoding IFN-γR/Fc (2000) (140)
BINDING OF SOLUBLE IMMUNE COMPLEXES TO HUMAN LYMPHOBLASTOID CELLS (1974) (134)
Molecular genetics of murine lupus models. (1989) (131)
The new paradigm of T-cell homeostatic proliferation-induced autoimmunity. (2005) (127)
T cell homeostasis and systemic autoimmunity. (2001) (125)
Quantitative polymerase chain reaction analysis reveals marked overexpression of interleukin-1β, interleukin-10 and interferon-γ mRNA in the lymph nodes of lupus-prone mice (1995) (125)
Inflammation and autoimmunity caused by a SHP1 mutation depend on IL-1, MyD88, and a microbial trigger (2008) (116)
The lupus-related Lmb3 locus contains a disease-suppressing Coronin-1A gene mutation. (2008) (115)
Tolerance-related V beta clonal deletions in normal CD4-8-, TCR- alpha/beta + and abnormal lpr and gld cell populations (1989) (115)
Sensors of the innate immune system: their mode of action (2009) (114)
Association of lpr gene with graft-vs.-host disease-like syndrome (1985) (113)
Influence of thymic genotype on the systemic lupus erythematosus-like disease and T cell proliferation of MRL/Mp-lpr/lpr mice (1981) (111)
The molecular pathology of autoimmune diseases (2002) (110)
The effect of thymectomy on lupus-prone mice. (1984) (108)
IgM rheumatoid factor and low molecular weight IgM. An association with vasculitis. (1974) (108)
Essential requirement for IRF8 and SLC15A4 implicates plasmacytoid dendritic cells in the pathogenesis of lupus (2013) (107)
RECEPTOR FOR SOLUBLE C3 AND C3b ON HUMAN LYMPHOBLASTOID (RAJI) CELLS (1974) (105)
Commitment to the Regulatory T Cell Lineage Requires CARMA1 in the Thymus but Not in the Periphery (2009) (104)
Efficient T cell activation via a Toll-Interleukin 1 Receptor-independent pathway. (2006) (103)
Demonstration of circulating immune complexes in Sjögren's syndrome. (1979) (103)
Detection and partial characterization of circulating immune complexes with solid-phase anti-C3. (1980) (102)
Role of Cyclin Kinase Inhibitor p21 in Systemic Autoimmunity1 2 (2001) (102)
Replication of dengue and junin viruses in cultured rabbit and human endothelial cells (1978) (101)
Use of bovine conglutinin for the assay of immune complexes. (1977) (101)
Male determined accelerated autoimmune disease in BXSB mice: transfer by bone marrow and spleen cells. (1980) (100)
Clonal characteristics of T cell infiltrates in skin and synovium of patients with psoriatic arthritis. (1999) (98)
Immune complexes in human diseases: a review. (1980) (98)
Replication of dengue-2 virus in cultured human lymphoblastoid cells and subpopulations of human peripheral leukocytes. (1976) (97)
Tumour necrosis factor and other cytokines in murine lupus (1999) (97)
B cell dependence on and response to accessory signals in murine lupus strains (1983) (96)
Genetic elements used for a murine lupus anti-DNA autoantibody are closely related to those for antibodies to exogenous antigens (1985) (93)
Anti–IFN-α/β Receptor Antibody Treatment Ameliorates Disease in Lupus-Predisposed Mice (2012) (92)
Clonal diversity and T-cell receptor beta-chain variable gene expression in enlarged lymph nodes of MRL-lpr/lpr lupus mice. (1986) (91)
Immunoglobulin kappa light chain variable region gene complex organization and immunoglobulin genes encoding anti-DNA autoantibodies in lupus mice. (1988) (90)
Polyclonality and multispecificity of the CTL response to a single viral epitope. (1998) (88)
Genomically imposed and somatically modified human thymocyte V beta gene repertoires. (1991) (88)
A comparative immunologic analysis of several murine strains with autoimmune manifestations. (1980) (87)
Genetics of SLE in mice (2006) (86)
Sensors of the innate immune system: their link to rheumatic diseases (2010) (85)
Detection of circulating immune complexes in patients with glomerulonephritis. (1977) (81)
Multiple autoantigen binding capabilities of mouse monoclonal antibodies selected for rheumatoid factor activity (1984) (80)
The genetic origin of autoantibodies. (1987) (80)
IgG rheumatoid factor in subacute bacterial endocarditis: relationship to IgM rheumatoid factor and circulating immune complexes. (1978) (79)
Etiology and pathogenesis of a spontaneous lupus-like syndrome in mice. (1978) (78)
Deficiency of the Cyclin Kinase Inhibitor p21(WAF-1/CIP-1) Promotes Apoptosis of Activated/Memory T Cells and Inhibits Spontaneous Systemic Autoimmunity (2004) (77)
γδ T Cell Homeostasis Is Controlled by IL-7 and IL-15 Together with Subset-Specific Factors1 (2005) (76)
Suggestive evidence for association of human chromosome 18q12-q21 and its orthologue on rat and mouse chromosome 18 with several autoimmune diseases. (2001) (75)
A Slfn2 mutation causes lymphoid and myeloid immunodeficiency due to loss of immune cell quiescence (2010) (74)
Incomplete T cell receptor V beta allelic exclusion and dual V beta-expressing cells. (1995) (71)
Immune complexes in hepatitis B antigen-associated periarteritis nodosa. Detection by antibody-dependent cell-mediated cytotoxicity and the Raji cell assay. (1977) (68)
Treatment of murine lupus with cDNA encoding IFN-gammaR/Fc. (2000) (65)
Thymic selection of the human T cell receptor V beta repertoire in SCID- hu mice (1992) (65)
Production of interleukin 2 (IL 2) by salivary gland lymphocytes in Sjögren's syndrome. Detection of reactive cells by using antibody directed to synthetic peptides of IL 2. (1985) (65)
Abnormalities of pulmonary vascular dynamics and inflammation in early progressive systemic sclerosis. (1981) (63)
Induction of severe autoimmune disease in normal mice by simultaneous action of multiple immunostimulators (1985) (62)
Thrombotic thrombocytopenic purpura-like syndrome associated with infective endocarditis. A possible immune complex disorder. (1977) (62)
Intracellular nucleic acid sensors and autoimmunity. (2011) (62)
Delineation of a defect in T cell receptor beta genes of NZW mice predisposed to autoimmunity (1986) (62)
Evidence for the presence of receptors for C3 and IgG Fc on human synovial cells. (1980) (61)
Immune complexes associated with neoplasia: presence of Epstein-Barr virus antigen-antibody complexes in Burkitt's lymphoma. (1974) (61)
Expression of protein‐tyrosine phosphatases in the major insulin target tissues (1997) (61)
Autoimmune diseases: immunopathology and etiopathogenesis. (1982) (61)
Lack of Intrinsic CTLA-4 Expression Has Minimal Effect on Regulation of Antiviral T-Cell Immunity (2006) (60)
Proliferative arrest and cell cycle regulation in CD8(+)CD28(-) versus CD8(+)CD28(+) T cells. (2002) (60)
Genetic studies of autoimmunity and retrovirus expression in crosses of New Zealand black mice. II. The viral envelope glycoprotein gp70 (1978) (60)
Inhibition of T cells proliferation and SLE-like syndrome of MRL/1 mice by whole body or total lymphoid irradiation. (1980) (59)
Immune pathology associated with altered actin cytoskeleton regulation (2010) (59)
Isolation of circulating immune complexes using Raji cells. Separation of antigens from immune complexes and production of antiserum. (1978) (59)
Immunotherapeutic gene transfer into muscle. (2001) (59)
New human V beta genes and polymorphic variants. (1991) (56)
Complexity and sequence identification of 24 rat V beta genes. (1991) (56)
Use of circulating immune complex levels in the serodifferentiation of endocarditic and nonendocarditic septicemias. (1979) (55)
Type I interferon is a therapeutic target for virus-induced lethal vascular damage (2014) (55)
Isotypic profiles and other fine characteristics of immune responses to exogenous thymus-dependent and -independent antigens by mice with lupus syndromes. (1983) (54)
Tumor-targeted IL-2 amplifies T cell-mediated immune response induced by gene therapy with single-chain IL-12. (1999) (54)
Identification of clonally expanded T cells in rheumatoid arthritis using a sequence enrichment nuclease assay. (1996) (52)
The proliferative in vivo activities of lpr double-negative T cells and the primary role of p59fyn in their activation and expansion. (1997) (50)
Ig heavy chain variable region gene complex of lupus mice exhibits normal restriction fragment length polymorphism (1985) (50)
Histidine-Rich Glycoprotein Binds to DNA and FcγRI and Potentiates the Ingestion of Apoptotic Cells by Macrophages1 (2002) (50)
Natural thymocytotoxic autoantibodies in autoimmune and normal mice. (1979) (49)
The genes of systemic autoimmunity. (1999) (49)
T‐Cell Receptor Vβ Repertoire Expression in Murine Models of SLE (1990) (49)
Monoclonal antibodies against complement 3 neoantigens for detection of immune complexes and complement activation. Relationship between immune complex levels, state of C3, and numbers of receptors for C3b. (1985) (48)
G1 arrest and high expression of cyclin kinase and apoptosis inhibitors in accumulated activated/memory phenotype CD4+ cells of older lupus mice (1997) (48)
Systemic Autoimmunity and Lymphoproliferation Are Associated with Excess IL-7 and Inhibited by IL-7Rα Blockade (2011) (47)
Rosette formation of human lymphoid cells with monkey red blood cells. (1975) (46)
Monoclonal IgM rheumatoid factors derived from arthritic MRL/Mp-lpr/lpr mice (1983) (46)
Elevated titers of cell-free interleukin 2 receptor in serum of lupus mice. (1987) (46)
Qualitative and quantitative requirements for CD4+ T cell-mediated antiviral protection. (1999) (45)
T-cell receptor alpha-chain variable-region haplotypes of normal and autoimmune laboratory mouse strains. (1988) (45)
The Role of αβ+ T Cells and Homeostatic T Cell Proliferation in Y-Chromosome-Associated Murine Lupus1 (2001) (44)
V beta gene repertoires in aging mice. (1992) (43)
TLRs and interferons: a central paradigm in autoimmunity. (2013) (43)
Discovery of peptoid ligands for anti-aquaporin 4 antibodies. (2013) (43)
Binding of components of the properdin system to cultured human lymphoblastoid cells and B lymphocytes (1976) (42)
Genetic contributions to SLE. (1996) (42)
Inhibition of Lupus by Genetic Alteration of the Interferon-α/β Receptor (2003) (41)
Molecular analysis of the murine lupus‐associated anti‐self response: involvement of a large number of heavy and light chain variable region genes (1987) (40)
Quantitative polymerase chain reaction analysis reveals marked overexpression of interleukin-1 beta, interleukin-1 and interferon-gamma mRNA in the lymph nodes of lupus-prone mice. (1995) (39)
Inhibition of Transmethylation Down-Regulates CD4 T Cell Activation and Curtails Development of Autoimmunity in a Model System (2007) (39)
Role of Nucleic Acid–Sensing TLRs in Diverse Autoantibody Specificities and Anti-Nuclear Antibody–Producing B Cells (2013) (39)
Application of a multiprobe RNase protection assay and junctional sequences to define V beta gene diversity in Sezary syndrome. (1992) (39)
Circulating immune complexes in pulmonary eosinophilic granuloma. (1979) (38)
Lpr T cell hyporesponsiveness to mitogens linked to deficient receptor-stimulated phosphoinositide hydrolysis. (1988) (38)
Mycoplasma arthritidis mitogen. Vβ engaged in mice, rats, and humans, and requirement of HLA‐DRα for presentation (1992) (37)
Patterns of immune reactivity in autoimmune murine strains. I. Cell-mediated immune responses induced by H-2 indentical and H-2 incompatible stimulator cells. (1979) (36)
Coding sequence polymorphisms among V beta T cell receptor genes. (1990) (36)
Neurological disease associated with Mycoplasma pneumoniae pneumonitis: demonstration of viable Mycoplasma pneumoniae in cerebrospinal fluid and blood by radioisotopic and immunofluorescent tissue culture techniques. (1981) (36)
Bacterial superantigens mediate T cell deletions in the mouse severe combined immunodeficiency-human liver/thymus model (1993) (35)
Oligoclonal CD4(+) T cell expansions in lung transplant recipients with obliterative bronchiolitis. (2002) (35)
Interferon-g is Required for Lupus-like Disease and Lymphoaccumulation in MRL-lpr Mice (34)
Thymic dendritic cells traffic to thymi of allogeneic recipients and prolong graft survival. (2002) (34)
Antibodies of predetermined specificity against chemically synthesized peptides of human interleukin 2. (1984) (34)
Terminal Deoxynucleotidyl Transferase Deficiency Decreases Autoimmune Disease in MRL-Faslpr Mice1 2 (2001) (34)
Report on international comparative evaluation of possible value of assays for immune complexes for diagnosis of human breast cancer (1981) (34)
B-cell hyperactivity in murine lupus I. Immunological abnormalities in lupus-prone strains and the activation of normal B cells. (1983) (33)
Immunopathogenetic aspects of infective endocarditis. (1990) (33)
Development of Lupus in BXSB Mice Is Independent of IL-41 (2000) (33)
Macrophage I-A/I-E expression and macrophage-stimulating lymphokines in murine lupus. (1984) (33)
Immune complexes in cancer. (1982) (32)
T cell receptor biases and clonal proliferations among lung transplant recipients with obliterative bronchiolitis. (1996) (32)
Novel origin of lpr and gld cells and possible implications in autoimmunity. (1990) (32)
Tumor immunity via homeostatic T cell proliferation: mechanistic aspects and clinical perspectives (2005) (31)
An autosomal recessive gene that delays expression of lupus in BXSB mice. (1991) (30)
Lysis of human cultured lymphoblastoid cells by cell-induced activation of the properdin pathway. (1977) (30)
Specificity and molecular characteristics of monoclonal IgM rheumatoid factors from arthritic and non-arthritic mice. (1987) (30)
Deletion of IgG-Switched Autoreactive B Cells and Defects in Faslpr Lupus Mice (2010) (29)
Paucity of V-D-D-J Rearrangements and VH Replacement Events in Lupus Prone and Nonautoimmune TdT−/− and TdT+/+ Mice1 (2006) (29)
Role of the thymus in murine lupus and cellular transfer of the disease. (1982) (29)
Autoimmune aspects of systemic lupus erythematosus. (1985) (29)
Autoimmune Alterations Induced by the New Zealand Black Lbw2 Locus in BWF1 Mice1 (2005) (29)
A microassay for the determination of hemolytic complement activity in mouse serum. (1978) (28)
Genetics of systemic autoimmunity. (1996) (28)
Interleukin-7 is required for CD4(+) T cell activation and autoimmune neuroinflammation. (2015) (28)
Yip1 domain family, member 6 (Yipf6) mutation induces spontaneous intestinal inflammation in mice (2012) (28)
TLRs and IFNs: critical pieces of the autoimmunity puzzle. (2012) (27)
Rational design of a Kv1.3 channel-blocking antibody as a selective immunosuppressant (2016) (26)
Terminal Deoxynucleotidyltransferase Deficiency Decreases Autoimmune Disease in Diabetes-Prone Nonobese Diabetic Mice and Lupus-Prone MRL-Faslpr Mice1 (2004) (26)
Presence of circulating immune complexes in Reiter's syndrome and ankylosing spondylitis (1981) (26)
Deletion of p21 (WAF-1/Cip1) Does Not Induce Systemic Autoimmunity in Female BXSB Mice1 (2002) (26)
Anticytokine gene therapy of autoimmune diseases (2001) (25)
Monoclonal autoantibodies reacting with multiple structurally related and unrelated macromolecules. (1988) (25)
B-cell hyperactivity in murine lupus II. Defects in response to and production of accessory signals in lupus-prone mice. (1983) (25)
Pulmonary immune complex deposition in Wegener's granulomatosis. (1982) (24)
IMMUNE COMPLEXES IN PREGNANCY (1978) (24)
Genomic composition and allelic polymorphisms influence V beta usage by the Mycoplasma arthritidis superantigen. (1993) (24)
Mechanisms and Genetics of Autoimmunity a (1998) (23)
Immune complexes in humoral immune responses: suppressive and enhancing effects. (1980) (23)
Circulating immune complexes in experimental streptococcal endocarditis: a monitor of therapeutic efficacy. (1979) (22)
Protein kinase C‐activating phorbol esters augment expression of T cell receptor genes (1987) (22)
T-cell receptor biases and clonal proliferations in blood and pleural effusions of patients with lung cancer. (1997) (21)
The role of alpha beta+ T cells and homeostatic T cell proliferation in Y-chromosome-associated murine lupus. (2001) (21)
V beta repertoire of murine hepatic T cells. Implication for selection of double negative alpha beta + T cells. (1994) (21)
Inhibition of lupus by genetic alteration of the interferon-alpha/beta receptor. (2003) (20)
Heterogeneity of T-cell receptor usage in experimental autoimmune neuritis in the Lewis rat. (1999) (20)
Human T helper cells specific for HIV reverse transcriptase: possible role in intrastructural help for HIV envelope‐specific antibodies (1995) (20)
Impaired negative regulation of homeostatically proliferating T cells. (2009) (20)
Transmethylation in immunity and autoimmunity. (2012) (20)
Immune Monitoring Protocol for Patients with Carcinoma of the Head and Neck (1978) (20)
The Biology of Immune Complexes and Their Possible Role in Pregnancy * (1981) (20)
T‐Cell Receptor Genes in Autoimmunity a (1993) (19)
Metabolism of autologous and homologous IgG in rheumatoid arthritis. (1977) (19)
Genetic diversity of murine rheumatoid factors. (1989) (18)
Detection of immune complexes: techniques and implications. (1980) (18)
Quantitation of circulating immune complexes, immunoglobulins G and M, and C3 complement component in patients with large periapical lesions. (1983) (18)
Characterization of Reciprocal Lmb1–4 Interval MRL-Faslpr and C57BL/6-Faslpr Congenic Mice Reveals Significant Effects from Lmb31 (2007) (18)
Genetic Complementation in Female (BXSB × NZW)F2 Mice 1 (2003) (17)
Evaluation and clinical significance of circulating immune complexes. (1980) (17)
Polynucleotide specificities of murine monoclonal anti-DNA antibodies. (1986) (16)
Mycoplasma arthritidis mitogen. V beta engaged in mice, rats, and humans, and requirement of HLA-DR alpha for presentation. (1992) (16)
Circulating immune complexes in prosthetic valve endocarditis. (1983) (16)
Differential expression profiles of apoptosis-affecting genes in HIV-infected cell lines and patient T cells. (1999) (16)
Intrathymic injection of polynucleosomes delays autoantibody production in BXSB mice. (1996) (14)
Molecular aspects of autoimmunity. (1989) (14)
Mechanisms and genetics of autoimmunity. (1998) (14)
Contribution of histidine-rich glycoprotein in clearance of immune complexes and apoptotic cells: Implications for ameliorating autoimmune diseases (2007) (13)
Surface and functional characteristics of B cells from lupus-prone murine strains. (1982) (13)
Induction of Systemic Autoimmunity by a Xenobiotic Requires Endosomal TLR Trafficking and Signaling from the Late Endosome and Endolysosome but Not Type I IFN (2017) (13)
Distribution of lymphocytes identified by surface markers in murine strains with sle-like syndromes. Abstr. (1979) (13)
Genes and genetics of autoimmunity (1999) (13)
Specificities of NZB anti-H-2d CML reactions: role of Qa-1 and retroviral gp70 antigens. (1981) (13)
Murine SLE - aetiology and pathogenesis. (1980) (13)
Vβ Gene Repertoire in the Aging Mouse: A Developmental Perspective (1995) (13)
8 – GENES AND GENETICS OF MURINE LUPUS (2004) (12)
Critical role of transmethylation in TLR signaling and systemic lupus erythematosus. (2013) (12)
An agonist antibody that blocks autoimmunity by inducing anti‐inflammatory macrophages (2016) (12)
The Lbw2 Locus Promotes Autoimmune Hemolytic Anemia (2012) (12)
Lack of relationship between serum gp70 levels and the severity of systemic lupus erythematosus in MRL/l mice (1986) (11)
Circulating immune complexes in Takayasu disease. (1980) (11)
Sequence of I-E genes from autoimmune New Zealand white mice. (1990) (11)
Lupus acceleration by a MAVS-activating RNA virus requires endosomal TLR signaling and host genetic predisposition (2018) (11)
Antibody-dependent cellular cytotoxicity against murine leukemia viral antigens: studies with human lymphoblastoid cell lines and human peripheral lymphocytes as effector cells comparing rabbit, goat, and mouse antisera. (1977) (11)
Genetics of systemic autoimmunity and glomerulonephritis in mouse models of lupus. (2001) (10)
Genetic susceptibility to spontaneous lupus in mice. (1999) (10)
Circulating immune complexes as possible cause for anticomplementary activity in humans with malignant melanoma (1979) (9)
Receptor for Native C3 on Human Lymphoblastoid Cell Lines (1973) (9)
Monoclonal Antibodies against Complement 3 Neoantigens for Detection of Immune Complexes and Complement Activation (9)
Genetic studies in systemic autoimmunity and aging (2000) (9)
The lesions of cyclosporine-induced autoimmune disease can be equally well elicited by CD4 or CD8 effector T cells. (1996) (9)
Analysis of pancreas-infiltrating T cells in diabetic NOD mice: fusion with BW5147 yields a high frequency of islet-reactive hybridomas. (1991) (8)
Circulating immune complexes in Takayasu disease. Lack of evidence for a causative role. (1981) (8)
The Raji, conglutinin, and anti-C3 assays for the detection of complement-fixing immune complexes. (1981) (8)
Silica exposure and chronic virus infection synergistically promote lupus-like systemic autoimmunity in mice with low genetic predisposition. (2019) (8)
B and T Cell antigen receptor repertoires in lupus/arthritis murine models (2004) (8)
Immune complexes (ICs) and pregnancy. Pregnancy as an IC-state or IC-disease and the influence of IC-diseases on pregnancy. (1980) (7)
B-cell suppression by anti-IgM antibody: humoral and cellular analyses. (1981) (7)
The solute carrier SLC15A4 is required for optimal trafficking of nucleic acid–sensing TLRs and ligands to endolysosomes (2022) (7)
Effector and predisposing genes in murine lupus (1998) (7)
T-cell receptor a-chain variable-region haplotypes ofnormaland autoimmune laboratory mousestrains (T-celi repertoire/imRNA expression/RNase protection assay/murine lupus/NOD mouse) (1988) (7)
Analysis of t cell function in autoimmune murine strains. Abstr. (1981) (6)
Abrogation of murine lupus by the xid gene is associated with reduced responsiveness of B cells to T-cell-helper signals. (1984) (6)
T‐Cell Repertoires in Health and Disease a (1995) (6)
Suppression of transferred BXSB male SLE disease by female spleen cells. (1982) (6)
I. Cell-mediated immune responses induced by h-2 identical and h-2 incompatible stimulator cells. (1979) (5)
Methods for the detection of soluble circulating immune complexes and their application. (1979) (5)
Lack of evidence for central T-cell tolerance defects in lupus mice and for V beta-deleting endogenous superantigens in rats and humans. (1992) (5)
T cell receptor V beta 15 dominates the antiacetylcholine receptor response in Lewis rat T cell lines. (1994) (5)
Genetics of Lupus in Mice (2011) (5)
Complexes with murine systemic lupus erythematosus. (1979) (4)
Inflammation and autoimmunity caused by a SHP1 mutation depend on IL-1, MyD88, and a microbial trigger (Proceedings of the National Academy of Sciences of the United States of America (2008) 105, 39, (15028-15033) DOI: 10.1073/pnas.0806619105) (2008) (4)
Systemic Lupus Erythematosus, Animal Models (1998) (4)
Plasmacytoid Dendritic Cells are the Primary Source of IFN-α During the Immunopathogenesis of Desiccating Stress-Induced Dry Eye Disease (2013) (4)
Genetic basis for autoantibody-production in murine models of systemic autoimmunity. (1989) (4)
CD1+ human thymocytes proliferate in response to superantigen staphylococcal enterotoxin B1. (1994) (4)
The activation of the alternative complement pathway by fetal calf serum and mouse thymocytes. (1979) (4)
V beta repertoire in rats and implications for endogenous superantigens. (1992) (4)
TOLERANCE-RELATED VO CLONAL DELETIONS IN NORMAL CD 4-8-, TCRa / 0 + AND ABNORMAL 1 pr AND g 1 d CELL POPULATIONS (2003) (4)
The role of IFN-γ in systemic lupus erythematosus : a challenge to the Th 1 / Th 2 paradigm in autoimmunity (2015) (3)
Genetics of Autoantibody Production in Mouse Models of Lupus (2006) (3)
Genomic organization and expression of B and T cell antigen receptor genes in murine lupus. (1987) (2)
Genes and genetics of murine systemic lupus erythematosus (2021) (2)
Current views on the pathogenesis of systemic lupus erythematosus. (1982) (2)
Immune complexes in infective endocarditis (2004) (2)
V beta gene repertoire in the aging mouse: a developmental perspective. (1995) (2)
Plasmacytoid Dendritic Cells are Modulated During the Immunopathogenesis of Desiccating Stress-Induced Experimental Dry Eye (2012) (2)
Immune Complexes in Human and Experimental Disease (1985) (2)
Molecular aspects of murine systemic lupus erythematosus (2005) (2)
Presence of circulation immune complexes in Reiter's syndrome and ankylosing spondylitis. (1981) (1)
Immunogene Therapy with Nonviral Vectors (2005) (1)
Molecular genetics of murine lupus (1986) (1)
Staining and fluorescence-activated cell sorter analysis of human lymphocytes using antibodies to a short, chemically synthesized human IL-2 peptide. (1985) (1)
Apoptotic Cells by Macrophages RI and Potentiates the Ingestion of γ and Fc Histidine-Rich Glycoprotein Binds to DNA (2002) (1)
Chapter 19 – Autoimmunity (2017) (1)
FLEx-autoAb transgenic mice, a novel mouse model for studying peripheral tolerance to B cells that acquire self-reactivity following somatic hypermutation. (P4034) (2013) (0)
IMMUNE COMPLEXES IN PREGNANCY (1978) (0)
Factors and IL-15 Together with Subset-Specific T Cell Homeostasis Is Controlled by IL-7 δγ (2005) (0)
GENOMIC AND EXPRESSED T CELL ANTIGEN RECEPTOR REPERTOIRE IN AUTOIMMUNE MURINE MODELS1 (1990) (0)
Section Reviews: Biologicals & Immunologicals: Sjögren's syndrome: Pathogenesis and prospects for therapy (1996) (0)
This information is current as Response to a Single Viral Epitope Polyclonality and Multispecificity of the CTL (1998) (0)
[Not Available]. (1985) (0)
Neurologic Disease Associated with Mycoplasma pneumoniae Pneumonitis (2020) (0)
Functional and surface characteristics of b cells derived from sle- -prone murine strains. Abstr. (1981) (0)
AI-21 Defective ikappabns leads to loss of peritoneal B1 cells and a reduction in induced but not spontaneous autoimmune hemolytic anaemia (2016) (0)
Replication ofDengueandJuninViruses inCultured Rabbit andHumanEndothelial Cellst (1978) (0)
Cell transfer studies in autoimmune bxsb mice. Abstr. (1979) (0)
Producing B Cells - Anti-nuclear Antibody Diverse Autoantibody Specificities and Sensing TLRs in - Role of Nucleic Acid (2017) (0)
Differential role of nucleic acid-sensing toll-like receptors in autoantibody production. (44.29) (2011) (0)
Author index (1999) (0)
The biology of immune complexes and their possible role in pregnancy. (1981) (0)
The role of peritoneal B-1a cells in spontaneous and induced autoimmune hemolytic anemia. (P4038) (2013) (0)
Cell transfer studies among mrl/mp-upr/lpr and mrl/mp-+/+ sle- -prone murine substrains. Abstr. (1981) (0)
1205 Treatment of Lupus-prone BXSB Mice with a Modulatable CAR T cell System Targeting CD19 (2022) (0)
Inhibition of nzb anti-h-2d cell mediated lympholysis (cml) by anti-gp70 antibody. Abstr. (1980) (0)
Cloning and Sequencing of Murine Lupus-Associated Autoantibody Genes (1988) (0)
Suppression of male bxsb sle by female bxsb spleen cells. Abstr. (1981) (0)
Book ReviewImmune Complexes in Clinical Experimental Medicine (1981) (0)
Contribution of the thymus in the disease of sle-prone mrl/mp- -lpr/lpr mice. Abstr. (1981) (0)
Experimental models for systemic autoimmune disease—Current concepts (1985) (0)
Model System Curtails Development of Autoimmunity in a Down-Regulates CD 4 T Cell Activation and Inhibition of Transmethylation Theofilopoulos (2007) (0)
MRL-Deficiency Decreases Autoimmune Disease in Terminal Deoxynucleotidyl Transferase (2001) (0)
Genomic organization and expression of antigen receptor genes in murine lupus (1987) (0)
Spontaneous rheumatoid-like arthritis and sjogren's disease. Abstr. (1982) (0)
Antigen receptor genes in autoimmune B and T cells. (1988) (0)
Independent of IL-4 Development of Lupus in BXSB Mice Is (1999) (0)
Immunologic assessment in clinical medicine. (1981) (0)
Isolation of Circulating Immune Complexes (1978) (0)
Modulation and reexpression of the t cell receptor tcr in neonatal normal and nzbxw lupus mice (1987) (0)
Circulating immune complexes in murine autoimmune disease. Abstr. (1977) (0)
AI-04 Immunotherapy for lupus in a mouse model to define pathogenesis and therapeutic targeting (2018) (0)
Hemolytic Anemia Locus Promotes Autoimmune Lbw2 The (0)
Are Rheumatoid Factors Produced During Conventional Immune Responses Beneficial to the Host? (2019) (0)
Effects of cyclosporin-a on in vitro and in vivo ig and anti-dna autoantibody production by splenocytes of autoimmune and normal mice. Abstr. (1982) (0)
Chemoproteomics-guided development of SLC15A4 inhibitors with anti-inflammatory activity (2022) (0)
Protection T Cell-Mediated Antiviral + for CD4 Qualitative and Quantitative Requirements (1999) (0)
Establishment of an 'in vitro' Model of Dengue Infection for the Study of Immunologic Events in this Disease (1974) (0)

This paper list is powered by the following services:

What Schools Are Affiliated With Argyrios N. Theofilopoulos?

Argyrios N. Theofilopoulos is affiliated with the following schools:

Argyrios N. Theofilopoulos's Academic­Influence.com Rankings

Why Is Argyrios N. Theofilopoulos Influential?

Argyrios N. Theofilopoulos's Published Works

Published Works

What Schools Are Affiliated With Argyrios N. Theofilopoulos?

Argyrios N. Theofilopoulos's AcademicInfluence.com Rankings